Ollendorf DA - Search Results

1

Frequency, predictors, and economic impact of upward dose adjustment of infliximab in managed care patients with rheumatoid arthritis.

Ollendorf DA, Massarotti E, Birbara C, Burgess SM. Ollendorf DA, et al. J Manag Care Pharm. 2005 Jun;11(5):383-93. doi: 10.18553/jmcp.2005.11.5.383. J Manag Care Pharm. 2005. PMID: 15934797 Free PMC article.

2

Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population.

Ollendorf DA, Peterson AN, Doyle J, Huse DM. Ollendorf DA, et al. Am J Manag Care. 2002 May;8(7 Suppl):S203-13. Am J Manag Care. 2002. PMID: 12022236 Free article.

3

Clinical and economic impact of glatiramer acetate versus beta interferon therapy among patients with multiple sclerosis in a managed care population.

Ollendorf DA, Jilinskaia E, Oleen-Burkey M. Ollendorf DA, et al. J Manag Care Pharm. 2002 Nov-Dec;8(6):469-76. doi: 10.18553/jmcp.2002.8.6.469. J Manag Care Pharm. 2002. PMID: 14740608

4

Impact of atypical antipsychotics on outcomes of care in schizophrenia.

Joyce AT, Harrison DJ, Loebel AD, Ollendorf DA. Joyce AT, et al. Among authors: ollendorf da. Am J Manag Care. 2005 Sep;11(8 Suppl):S254-61. Am J Manag Care. 2005. PMID: 16180964 Free article.

5

End-stage renal disease-associated managed care costs among patients with and without diabetes.

Joyce AT, Iacoviello JM, Nag S, Sajjan S, Jilinskaia E, Throop D, Pedan A, Ollendorf DA, Alexander CM. Joyce AT, et al. Among authors: ollendorf da. Diabetes Care. 2004 Dec;27(12):2829-35. doi: 10.2337/diacare.27.12.2829. Diabetes Care. 2004. PMID: 15562193

6

Infliximab drug and infusion costs among patients with Crohn's disease in a commercially-insured setting.

Ollendorf DA, Lidsky L. Ollendorf DA, et al. Am J Ther. 2006 Nov-Dec;13(6):502-6. doi: 10.1097/01.mjt.0000245223.43783.45. Am J Ther. 2006. PMID: 17122530

7

Differences in annual medication costs and rates of dosage increase between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population.

Ollendorf DA, Klingman D, Hazard E, Ray S. Ollendorf DA, et al. Clin Ther. 2009 Apr;31(4):825-35. doi: 10.1016/j.clinthera.2009.04.002. Clin Ther. 2009. PMID: 19446156

8

Effect of initial ziprasidone dose on length of therapy in schizophrenia.

Joyce AT, Harrison DJ, Loebel AD, Carter CT, Ollendorf DA. Joyce AT, et al. Among authors: ollendorf da. Schizophr Res. 2006 Apr;83(2-3):285-92. doi: 10.1016/j.schres.2006.01.009. Epub 2006 Mar 20. Schizophr Res. 2006. PMID: 16545543 Clinical Trial.

9

An examination of treatment patterns and costs of care among patients with benign prostatic hyperplasia.

Black L, Naslund MJ, Gilbert TD Jr, Davis EA, Ollendorf DA. Black L, et al. Among authors: ollendorf da. Am J Manag Care. 2006 Mar;12(4 Suppl):S99-S110. Am J Manag Care. 2006. PMID: 16551208 Free article.

10

Patterns of use, dosing, and economic impact of biologic agent use in patients with rheumatoid arthritis: a retrospective cohort study.

Gilbert TD Jr, Smith D, Ollendorf DA. Gilbert TD Jr, et al. Among authors: ollendorf da. BMC Musculoskelet Disord. 2004 Oct 14;5(1):36. doi: 10.1186/1471-2474-5-36. BMC Musculoskelet Disord. 2004. PMID: 15485582 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters